Katsushi Tokunaga - Genetic Mutations

Author Information

Katsushi Tokunaga is a distinguished researcher in the field of human genetics, affiliated with the Department of Human Genetics at the Graduate School of Medicine, University of Tokyo, Japan. His work is primarily focused on the genetic underpinnings of various health conditions, including responses to vaccines, hypersomnia, and cancer therapy. His affiliation with one of the leading institutions in Japan highlights his significant contributions to the field.

Research Contributions

Katsushi Tokunaga has made substantial contributions to the domain of genetics through his research on genetic markers and their implications in diseases and therapy responses. In 2022 alone, he has published extensively on topics such as the role of single-nucleotide polymorphisms in cancer therapy, associations between HLA alleles and neurological conditions, and genetic factors influencing COVID-19 responses. His work in identifying genetic variants associated with sleep disorders and drug reactions further underscores his diverse research interests and expertise in genetic characterization and association studies.

Aliases

Katsushi Tokunaga is also known by other aliases, including K Tokunaga and K. Tokunaga. These variations are commonly used across different publications and databases.

Publication and Citation Metrics

Metrics	Value
Total Citation Count	28,730
H-index	80
Total Paper Count	864

Publications:

A single-nucleotide-polymorphism in the 5′-flanking region of MSX1 gene as a predictive marker candidate for platinum-based therapy of esophageal carcinoma

DOI: 10.1177/17588359221080580

Year: 2022

Protective association of HLA-DPB1*04:01:01 with acute encephalopathy with biphasic seizures and late reduced diffusion identified by HLA imputation.

DOI: 10.1038/s41435-022-00170-y

Year: 2022

A rare genetic variant in the cleavage site of prepro-orexin is associated with idiopathic hypersomnia

DOI: 10.1038/s41525-022-00298-w

Year: 2022

Characterization of the novel HLA-A allele, A*24:02:01:111 in a Japanese individual.

DOI: 10.1111/tan.14635

Year: 2022

GWAS identifies candidate susceptibility loci and microRNA biomarkers for acute encephalopathy with biphasic seizures and late reduced diffusion

DOI: 10.1038/s41598-021-04576-y

Year: 2022

A variant in orexin receptor-2 is associated with self-reported daytime sleepiness in the Japanese population.

DOI: 10.1038/s10038-022-01015-2

Year: 2022

Genetic association of IL17 and the importance of ABO blood group antigens in saliva to COVID-19

DOI: 10.1038/s41598-022-07856-3

Year: 2022

An Association Study of HLA with the Kinetics of SARS-CoV-2 Spike Specific IgG Antibody Responses to BNT162b2 mRNA Vaccine

DOI: 10.3390/vaccines10040563

Year: 2022

Genetic characterization of N-acetyltransferase 2 variants in acquired multidrug-resistant tuberculosis in Indonesia.

DOI: 10.2217/pgs-2020-0163

Year: 2021

Mapping of susceptible variants for cold medicine-related Stevens–Johnson syndrome by whole-genome resequencing

DOI: 10.1038/s41525-021-00171-2

Year: 2021

What Role does Genetic Counseling Play?

What types of genetic mutations are associated with PAH exposure?

How Do Genetic Mutations Affect Immunotherapy?

What Role Do Genetic Mutations Play in Prenatal Screening?

How Does Genetic Counseling Help?

Why is Cellular Heterogeneity Important in Genetics?

How are inherited genetic mutations diagnosed?

How Reliable Are Prenatal Screening Tests?

How is the Delta F508 Mutation Inherited?

What Are the Consequences of Meiosis Errors?

Partnered Content Networks

Relevant Topics